Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 43

Results For "PROTECT"

621 News Found

JB Chemicals and Pharmaceuticals partners with Akshay Chaitanya to provide free lunch in hospitals
Sustainability | April 07, 2022

JB Chemicals and Pharmaceuticals partners with Akshay Chaitanya to provide free lunch in hospitals

Under this initiative, 700 meals will be provided every day to four hospitals in Mumbai


Pristyn Care’s new app enables location-based discovery of doctors
Startup | April 06, 2022

Pristyn Care’s new app enables location-based discovery of doctors

An upgraded, state-of-the-art integrated app, helps easy discovery of expert surgeons for convenient in-clinic or online consultation


ENTOD Pharma bullish on Macushield sales
News | April 06, 2022

ENTOD Pharma bullish on Macushield sales

Macushield tablets assist with age-related macular degeneration, diabetic retinopathy and improves overall vision


Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
Biotech | April 05, 2022

Good business performance gives Boehringer Ingelheim tailwind for investment in R&D

R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)


CanSinoBIO's Covid-19 mRNA vaccine receives clinical trial approval in China
Biotech | April 04, 2022

CanSinoBIO's Covid-19 mRNA vaccine receives clinical trial approval in China

CanSinoBIO will continue to focus on developing a variety of innovative preventive vaccines in its diversified product pipeline with proprietary technologies, including the inhaled version of its COVID-19 vaccine, Convidecia


Bayer to invest €1.3 billion for driving innovations in life sciences, agriculture segment
News | April 03, 2022

Bayer to invest €1.3 billion for driving innovations in life sciences, agriculture segment

Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024


USFDA clears IND application for an intranasal RSV vaccine
Biotech | March 29, 2022

USFDA clears IND application for an intranasal RSV vaccine

The companies are now preparing to initiate a Phase 1 trial to assess the safety and immunogenicity of BLB-201 in healthy volunteers


USFDA approves EUA for second booster dose of Moderna
News | March 29, 2022

USFDA approves EUA for second booster dose of Moderna

50 µg dose approved for all adults over 50 years of age and immunocompromised adults over 18 years of age


EU approves Evusheld to prevent Covid-19
Drug Approval | March 28, 2022

EU approves Evusheld to prevent Covid-19

Evusheld significantly reduced the risk of developing symptomatic COVID-19 in PROVENT Phase III trial, with protection lasting at least six months


Govt signs agreement with Sapigen Biologix to develop two vaccines
News | March 28, 2022

Govt signs agreement with Sapigen Biologix to develop two vaccines

Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project